Cereius
Durham, US · Founded 2017 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
EF
Edward FieldNamed on SEC filing
SH
Susie HarborthNamed on SEC filing
KB
Kimberly BlackwellNamed on SEC filing
MZ
Michael ZalutskyNamed on SEC filing
BH
Bill HawkinsNamed on SEC filing
Board
EL
Investors · 1
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2018
▶$1MraisedAug 2018 · 3 investors · BiotechnologyRule 506(b)
▶$1MraisedAug 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric LinsleyDirector
- Edward FieldExecutive Officer, Director
- Susie HarborthDirector
- Kimberly BlackwellExecutive Officer
- Michael ZalutskyExecutive Officer, Director
- Bill HawkinsDirector
- Offering amount
- $6M
- Amount sold
- $1M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Cereius's investors?
- Cereius's investors include BioInnovation Capital.
- How much funding has Cereius raised?
- Cereius has disclosed $1M raised across 1 round.
- Where is Cereius headquartered?
- Cereius is headquartered in Durham, US.